Parkinson's disease (PD) is a common neurodegenerative disorder. It has a delitescent
onset and a slow progress. The clinical manifestations of PD in patients are highly …

Parkinson's disease (PD) is a heterogeneous neurodegenerative disorder associated with
several motor and non-motor dysfunctions. The wide variety of clinical features often leads to …

The diagnostic performance of a combined architecture on Parkinson's disease using
diffusion tensor imaging was evaluated. A convolutional neural network was trained from …

Several studies have already assessed brain network variations in multiple sclerosis (MS)
patients and healthy controls (HCs). The underlying neural system's functioning is …

Mild cognitive impairment in Parkinson's disease (PD-M) is related to a high risk of
dementia. This study explored the whole-brain functional networks in early-stage PD-M …

While previous structural-covariance studies have an advanced understanding of brain
alterations in Parkinson's disease (PD), brain–behavior relationships have not been …

In Parkinson's disease (PD), iron accumulation in the substantia nigra (SN) exacerbates
oxidative stress and α-synuclein aggregation, leading to neuronal death. However, the …

Objectives Parkinson's disease (PD) is the second most common neurodegenerative
disorder which resists around 10 million people worldwide. It develops when nerve cells in a …

Background Parkinson's disease (PD) is characterized by loss of selectively vulnerable
neurons within the basal ganglia circuit and progressive atrophy in subcortical and cortical …

Objective. Delineating Parkinson's disease (PD) into distinct subtypes is a major challenge.
Most studies use clinical symptoms to label PD subtypes while our work uses an imaging …